Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile

Author:

Turner Nicholas A12ORCID,Warren Bobby G12,Gergen-Teague Maria F3,Addison Rachel M12,Addison Bechtler12,Rutala William A3,Weber David J3,Sexton Daniel J12,Anderson Deverick J12

Affiliation:

1. Duke University School of Medicine, Division of Infectious Diseases, Durham, North Carolina, USA

2. Duke Infection Control Outreach Network, Durham, North Carolina, USA

3. Division of Infectious Diseases, School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA

Abstract

Abstract Background Shedding of Clostridioides difficile spores from infected individuals contaminates the hospital environment and contributes to infection transmission. We assessed whether antibiotic selection affects C. difficile shedding and contamination of the hospital environment. Methods In this prospective, unblinded, randomized controlled trial of hospitalized adults with C. difficile infection, patients were randomized 1:1:1 to receive fidaxomicin, oral vancomycin, or metronidazole. The primary outcome was change in environmental contamination rate during treatment. Secondary outcomes included stool shedding, total burden of contamination, and molecular relatedness of stool versus environmental C. difficile isolates. Results Of 33 patients enrolled, 31 (94%) completed the study. Fidaxomicin (−0.36 log10 colony-forming units [CFUs]/d [95% confidence interval (CI), −.52 to −.19]; P < .01) and vancomycin (−0.17 log10 CFUs/d [−.34 to −.01]; P = .05) were associated with more rapid decline in C. difficile shedding than metronidazole (−0.01 log10 CFUs/d [95% CI, −.10 to .08). Both vancomycin (6.3% [95% CI, 4.7–8.3) and fidaxomicin (13.1% [10.7–15.9]) were associated with lower rates of environmental contamination than metronidazole (21.4% [18.0–25.2]). With specific modeling of within-subject change over time, fidaxomicin (adjusted odds ratio, 0.83 [95% CI, .70–.99]; P = .04) was associated with more rapid decline in environmental contamination than vancomycin or metronidazole. Overall, 207 of 233 environmental C. difficile isolates (88.8%) matched patient stool isolates by ribotyping, without significant difference by treatment. Conclusions Fidaxomicin, and to a lesser extent vancomycin, reduces C. difficile shedding and contamination of the hospital environment relative to metronidazole. Treatment choice may play a role in reducing healthcare-associated C. difficile transmission.

Funder

Merck

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3